Syngene International Appoints Peter Bains as CEO After Hunt Steps Down

Introduction to the Leadership Change

Syngene International, a leading contract research, development, and manufacturing organization (CRDMO), has announced a significant change in its executive leadership. Effective February 10, 2025, Jonathan Hunt has stepped down from his position as Managing Director and Chief Executive Officer. The company's board has appointed Peter Bains, a seasoned industry veteran and former CEO of the company, as the CEO Designate. This move marks a pivotal moment for the Bengaluru-based firm, signaling a return to familiar leadership to guide its next phase of growth.

The Board's Announcement

The transition was made public through a formal announcement, clarifying that Jonathan Hunt's departure was a decision to pursue other opportunities. Kiran Mazumdar-Shaw, the Non-Executive Chairperson of Syngene International, acknowledged Hunt's significant contributions to the company. In a statement, she thanked him for his service of nearly a decade, which began in April 2016. Mazumdar-Shaw highlighted his role in the substantial growth of Syngene's business and its impressive value enhancement during his tenure. The board extended its best wishes to Hunt for his future endeavors. The change is effective immediately, indicating a swift and decisive transition planned by the board.

A Familiar Face Returns to the Helm

Peter Bains is no stranger to Syngene International. His reappointment is a return to a role he held with distinction from June 2010 to March 2016. During his previous tenure, Bains was instrumental in building a strong foundation for the business. His most notable achievement was leading the company through its successful Initial Public Offering (IPO) in 2015, a key milestone that established Syngene as a major player in the public markets. His deep familiarity with the company's operations, culture, and strategic direction is considered a significant asset. The board expressed confidence that his domain experience and leadership acumen make him eminently qualified to step back into the role.

Peter Bains: A Profile of Experience

With over three decades of experience in the global biopharmaceutical and biotechnology sectors, Peter Bains brings a wealth of knowledge to the position. His career is marked by leadership roles that have shaped strategy and driven growth. Before his recent appointment as Group CEO of Biocon in September 2023, he also served as the CEO of Sosei Group (now Nxera Pharma), a Japanese-listed biopharmaceutical company. Bains holds a bachelor’s degree in Science, with combined honours in Zoology and Physiology, from the University of Sheffield, UK. His responsibilities at Syngene will involve overseeing strategy and execution, guiding investment decisions, and leading the executive team and business operations.

Jonathan Hunt's Decade of Leadership

Jonathan Hunt's tenure as MD & CEO spanned nearly ten years, a period of significant expansion for Syngene. Appointed in April 2016, he steered the company through a phase of sustained growth, building on the foundation laid before him. The chairperson's acknowledgment of his contribution to the company's